GE Finishes 1.5% Lower and 3 Must-See Dow Spotlight Stocks Monday

General Electric Company (NYSE:GE), as the parent firm of the Weather Channel Companies, will stop including the word “Channel” in its name, said The New York Times on Friday. The majority of The Weather Company’s growth originates from the Internet and specialized products for businesses and it foresees significant opportunities for growth in the global markets. NBCUniversal, which is owned by Comcast Corporation (NASDAQ:CMCSA) and GE, partially owns the Weather Company. In addition, The Blackstone Group (NYSE:BX) has a stake in the company.

Hewlett-Packard Company (NYSE:HPQ) has introduced HP Service Anywhere, which is a Software-as-a-Service information tech service management, consisting of a solution that produces a simple-to-use, modern experience that allows IT professionals to increase productivity while at the same time managing and delivering high-quality services. HP Service Anywhere unites key technologies, such as the market-leading HP Universal Configuration Management Database which manages services, applications and hardware across the IT environment, and is populated and maintained via HP Universal Discovery software, which automates discovery and dependency mapping of relevant IT elements.

Catalysts are critical to discovering winning stocks. Check out our newest CHEAT SHEET stock picks now.

JPMorgan Chase & Co. (NYSE:JPM) as one of the world’s largest bond traders, said that the Federal Reserve will make a decision before the end of 2012 to buy Treasuries in addition to $40 billion of mortgage bonds per month as gains in domestic employment and consumer confidence become unsustainable. There are 21 primary dealers which trade with the Fed, and all expect that its most recent quantitative-easing measures will be expanded to include government securities, says a survey by Bloomberg News.

Merck & Co. (NYSE:MRK) will pay a $2 million milestone payment to Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) through the terms of a development and license collaboration for the development of dinaciclib. The payment was triggered by the beginning of a Phase 2b/3 adaptive clinical trial for dinaciclib to treat patients suffering from refractory chronic lymphocytic leukemia.

Don’t Miss: Are Apple and Samsung Really Breaking Up?